News & Perspective

Apr 01, 2004

Apr 01, 2004

IDSA urges Bayer to stop selling enrofloxacin

(CIDRAP News) – The Infectious Diseases Society of America (IDSA) is urging Bayer Corp. to comply with a proposed federal regulatory action and withdraw enrofloxacin (Baytril) from the market because of the concern that its use in poultry promotes drug-resistant bacteria.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


  Become an underwriter»